Osimertinib for EGFR T790M mutation-positive non-small cell lung cancer

  • Kenzo Soejima, Hiroyuki Yasuda, Toshiyuki Hirano
  • Expert Review of Clinical Pharmacology, December 2016, Taylor & Francis
  • DOI: 10.1080/17512433.2017.1265446

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1080/17512433.2017.1265446